Overview

Forced-dose Titration of SPD489 in Adults With Binge Eating Disorder

Status:
Completed
Trial end date:
2012-01-30
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of SPD489 compared to placebo in the treatment of moderate to severe binge eating disorder as measured by the number of binge days per week
Phase:
Phase 2
Details
Lead Sponsor:
Shire
Treatments:
Lisdexamfetamine Dimesylate